Antisense Oligonucleotide-Based Therapy in Human Erythropoietic Protoporphyria
Page 1 of 1
Antisense Oligonucleotide-Based Therapy in Human Erythropoietic Protoporphyria
Jon Moulton Tue Apr 01, 2014 10:31 am
Oustric V, Manceau H, Ducamp S, Soaid R, Karim Z, Schmitt C, Mirmiran A, Peoc'h K, Grandchamp B, Beaumont C, Lyoumi S, Moreau-Gaudry F, Guyonnet-Dupérat V, de Verneuil H, Marie J, Puy H, Deybach JC, Gouya L. Antisense Oligonucleotide-Based Therapy in Human Erythropoietic Protoporphyria. Am J Hum Genet. 2014 Mar 26. pii: S0002-9297(14)00068-8. doi: 10.1016/j.ajhg.2014.02.010. [Epub ahead of print]
Jon Moulton- Posts : 5721
Join date : 2010-03-12
Age : 62
Location : Philomath, Oregon, USA -
Similar topics» Altered Levels of MicroRNA-9, -206, and -132 in Spinal Muscular Atrophy and Their Response to Antisense Oligonucleotide Therapy
» Antisense-based RNA therapy of factor V deficiency: in vitro and ex vivo rescue of a F5 deep-intronic splicing mutation
» Antisense Oligonucleotide Induction of Progerin in Human Myogenic Cells
» Antisense Oligonucleotide-mediated Suppression of Muscle Glycogen Synthase 1 Synthesis as an Approach for Substrate Reduction Therapy of Pompe Disease
» Oligonucleotide-based tools for studying zebrafish development
» Antisense-based RNA therapy of factor V deficiency: in vitro and ex vivo rescue of a F5 deep-intronic splicing mutation
» Antisense Oligonucleotide Induction of Progerin in Human Myogenic Cells
» Antisense Oligonucleotide-mediated Suppression of Muscle Glycogen Synthase 1 Synthesis as an Approach for Substrate Reduction Therapy of Pompe Disease
» Oligonucleotide-based tools for studying zebrafish development
Page 1 of 1
Permissions in this forum:
You cannot reply to topics in this forum